TL
Tiziana Life Sciences Ltd
TLSA · NASDAQ
$0.89 -0.01% (-$0.00)
1M -21.34%
Market Cap $58.5M
P/E Ratio -
Div. Yield -
ROE 490.09%
Bulios Fair Price
$0.45
49.4% downside
Trenutna cena
$0.89
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TLSA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 1,124.90x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Book val. growth 86.15%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 160.34%
ROIC 4,189.76%
Asset turnover 0.00x
Debt
5 /100
High Int. coverage -1,182.44x
Debt/Equity 8.77x
Current ratio 0.76x
Stability
41 /100
Moderate Profitable years 0
Beta 0.45x
EPS volatility 47.65%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TLSA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ivor R. Elrifi
Employees
10
Headquarters
London